GeNeuro
Innovating by targeting the cause of diseases potentially mediated by endogenous retroviruses - multiple sclerosis, certain neuropathies, diabetes, schizophrenia.
Market cap
$1.0m
Enterprise value
$14m
Share price
€0.03 GNRO.PA
Company register number
CH-660.0.307.006-3
Authorizing premium user...